Skip to main content
Blueberries Medical Corp. logo

Blueberries Medical Corp. — Investor Relations & Filings

Ticker · BBM LEI · 8755001E8GPPOC50L637 CSE Manufacturing
Open in API
Filings indexed 84 across all filing types
Latest filing 2025-05-28 Regulatory Filings
Country CA Canada
Listing CSE BBM

About Blueberries Medical Corp.

https://www.blueberriesmed.com/

Blueberries Medical Corp. is a licensed producer and developer specializing in the transformation and commercialization of natural plant compounds, primarily cannabis derivatives, into science-based wellness products. The company produces both psychoactive (THC) and non-psychoactive (CBD) by-products, including isolates, distillates, resins, and full/broad spectrum extracts. Key offerings include CBD Isolate, water-soluble CBD, THC resin, THC distillate, and various flower derivatives. Additionally, it distributes functional supplements and natural wellness products. Operating as part of the Terraflos ecosystem, Blueberries serves the health and wellness sector by developing alternative therapies. Products are commercialized internationally, adhering to destination country regulations.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Venture Issuer Basic Certificate” certifying the interim filings (interim financial report and MD&A) for the period ended March 31, 2025. It is not the interim report itself but a statutory certification under NI 52-109. It does not announce financial results, board changes, dividends, or other specific categories. It is a regulatory document submitted as part of securities compliance, fitting the fallback “Regulatory Filings” category.
2025-05-28 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 certification (a statutory officer’s certificate) of review for interim filings, not the interim financial report itself. It does not present financial results but provides a regulatory certificate under Canadian NI 52-109. This does not fit any specific reporting category (e.g., IR, AR) but is a miscellaneous regulatory filing. Thus, it falls under the fallback category “Regulatory Filings (RNS).”
2025-05-28 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Condensed Interim Consolidated Financial Statements' for the three months ended March 31, 2025. It contains comprehensive financial statements including the Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Changes in Equity, and Statement of Cash Flows, along with detailed explanatory notes. It is a full interim financial report, not an announcement or a summary, and meets the criteria for an Interim/Quarterly Report (IR). Q1 2025
2025-05-28 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV1 certification by the CFO relating to the issuer’s annual filings (AIF, financial statements, MD&A) under Canadian NI 52-109. It is not the full annual report itself, nor an announcement of report publication, but a required regulatory certificate. Therefore it fits the fallback category for miscellaneous regulatory filings.
2025-04-24 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV1 Venture Issuer Basic Certificate under Canadian NI 52-109 regulations. It is a certifying officer’s statement confirming review and fair presentation of annual filings (AIF, financial statements, MD&A) for the year ended December 31, 2024. It is not the actual annual report (10-K or IR), nor an earnings release, dividend notice, or management discussion. It is a regulatory compliance filing by the issuer. No specific category exists for certification forms, so it defaults to Regulatory Filings (RNS).
2025-04-24 English
Annual MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for the year ended December 31, 2024 and provides detailed commentary on financial results, business trends, outlook, and operational highlights. This matches the definition for a Management Report (MDA). It is not the full annual report nor merely an announcement or summary, but the standalone MD&A section.
2025-04-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.